Skip to content

Patient Case: Kaposi’s Sarcoma (KS)

Discussion

A 45-year-old man presents to the dermatology clinic with multiple dark red to purple patches on his lower legs, which have gradually increased in number and size over the past six months. He reports mild itching and occasional pain in the lesions but denies any significant bleeding. Recently, he has also noticed some swelling in his legs.

His medical history includes an unexplained weight loss of 7 kg (15 lbs) over the past year, occasional night sweats, and a persistent dry cough. On examination, there are multiple violaceous, non-blanching nodules and plaques scattered on both lower legs, with some extending to the trunk and oral mucosa. There is also mild bilateral lower limb edema.

Given the patient’s symptoms and lesion distribution, further investigations, including an HIV test and CD4 count, are ordered. The HIV test returns positive, with a low CD4 count, confirming advanced immunosuppression. A skin biopsy of one of the lesions reveals spindle cell proliferation with vascular slits, consistent with Kaposi’s sarcoma.

The patient is referred to an infectious disease specialist for antiretroviral therapy (ART) initiation and an oncologist for evaluation of systemic involvement. He is counseled on the need for combination ART as the mainstay of treatment, with additional options such as chemotherapy or radiotherapy for extensive or symptomatic lesions.

Questions
  1. What is the primary cause of Kaposi’s sarcoma?
    a) Epstein-Barr virus (EBV)
    b) Human herpesvirus-8 (HHV-8)
    c) Cytomegalovirus (CMV)
    d) Human papillomavirus (HPV)
  2. Which population is at the highest risk for developing Kaposi’s sarcoma?
    a) Patients with poorly controlled HIV/AIDS
    b) Elderly individuals with no underlying conditions
    c) Children under 10 years of age
    d) People with a history of smoking
  3. What is the first-line treatment for Kaposi’s sarcoma in HIV-positive patients?
    a) Surgical excision of lesions
    b) Antiretroviral therapy (ART)
    c) Topical corticosteroids
    d) Radiation therapy
  4. Which of the following is a common systemic involvement in Kaposi’s sarcoma?
    a) Brain metastases
    b) Gastrointestinal and pulmonary lesions
    c) Bone marrow suppression
    d) Autoimmune arthritis
Reveal answers

Answers

  1. (b) Human herpesvirus-8 (HHV-8)
    • KS is caused by HHV-8, which leads to abnormal vascular proliferation, especially in immunocompromised individuals.
  2. (a) Patients with poorly controlled HIV/AIDS
    • KS is an AIDS-defining illness and occurs most commonly in individuals with advanced immunosuppression. It is also seen in organ transplant recipients and elderly Mediterranean men.
  3. (b) Antiretroviral therapy (ART)
    • In HIV-associated KS, ART helps restore immune function, leading to regression of lesions. Additional treatments like chemotherapy or radiotherapy are considered for extensive disease.
  4. (b) Gastrointestinal and pulmonary lesions
    • In advanced KS, internal organs such as the lungs and GI tract can be involved, leading to symptoms like hemoptysis, GI bleeding, or respiratory distress.

 

Are you a Medical Doctor?